長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4540】ツムラ

【4540】ツムラ
医療用漢方薬。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 ロート製薬 日本新薬


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/07 Q2予 185,000 → 0.0% 0.0% 39,500 → 0.0% 0.0% 39,500 → 0.0% 0.0% 28,500 → 0.0% 0.0%
2025.03 2024/08/05 Q1予 185,000 → 0.0% 0.0% 39,500 → 0.0% 0.0% 39,500 → 0.0% 0.0% 28,500 → 0.0% 0.0%
2025.03 2024/05/09 当初予 185,000 - - - 39,500 - - - 39,500 - - - 28,500 - - -
2024.03 2024/05/09 実 150,845 ↓ -0.8% +0.2% 20,017 ↑ +2.7% +11.2% 23,493 ↑ +4.9% +26.3% 16,707 ↑ +3.1% +28.5%
2024.03 2024/02/06 Q3予 152,000 ↑ +1.0% +1.0% 19,500 ↑ +8.3% +8.3% 22,400 ↑ +20.4% +20.4% 16,200 ↑ +24.6% +24.6%
2024.03 2023/11/07 Q2予 150,500 → 0.0% 0.0% 18,000 → 0.0% 0.0% 18,600 → 0.0% 0.0% 13,000 → 0.0% 0.0%
2024.03 2023/11/01 修正予 - - - - - - - - - - - - - - - -
2024.03 2023/08/03 Q1予 150,500 → 0.0% 0.0% 18,000 → 0.0% 0.0% 18,600 → 0.0% 0.0% 13,000 → 0.0% 0.0%
2024.03 2023/05/09 当初予 150,500 - - - 18,000 - - - 18,600 - - - 13,000 - - -
2023.03 2023/05/09 実 140,043 ↑ +1.1% +1.1% 20,916 ↑ +0.6% +0.6% 23,453 ↑ +10.6% +10.6% 16,482 ↑ +9.9% +9.9%
2023.03 2023/02/03 Q3予 138,500 → 0.0% 0.0% 20,800 → 0.0% 0.0% 21,200 → 0.0% 0.0% 15,000 → 0.0% 0.0%
2023.03 2022/11/04 Q2予 138,500 → 0.0% 0.0% 20,800 → 0.0% 0.0% 21,200 → 0.0% 0.0% 15,000 → 0.0% 0.0%
2023.03 2022/08/03 Q1予 138,500 → 0.0% 0.0% 20,800 → 0.0% 0.0% 21,200 → 0.0% 0.0% 15,000 → 0.0% 0.0%
2023.03 2022/05/10 当初予 138,500 - - - 20,800 - - - 21,200 - - - 15,000 - - -
2022.03 2022/05/10 実 129,546 ↑ +1.6% +5.8% 22,376 ↑ +6.0% +14.7% 25,904 ↑ +10.7% +29.5% 18,836 ↑ +13.5% +32.6%
2022.03 2022/02/04 Q3予 127,500 → 0.0% +4.1% 21,100 → 0.0% +8.2% 23,400 → 0.0% +17.0% 16,600 → 0.0% +16.9%
2022.03 2021/11/05 Q2予 127,500 → 0.0% +4.1% 21,100 → 0.0% +8.2% 23,400 → 0.0% +17.0% 16,600 → 0.0% +16.9%
2022.03 2021/10/29 修正予 127,500 ↑ +4.1% +4.1% 21,100 ↑ +8.2% +8.2% 23,400 ↑ +17.0% +17.0% 16,600 ↑ +16.9% +16.9%
2022.03 2021/08/05 Q1予 122,500 → 0.0% 0.0% 19,500 → 0.0% 0.0% 20,000 → 0.0% 0.0% 14,200 → 0.0% 0.0%
2022.03 2021/05/11 当初予 122,500 - - - 19,500 - - - 20,000 - - - 14,200 - - -
2021.03 2021/05/11 実 130,883 ↑ +0.3% -0.8% 19,382 ↑ +0.4% +14.0% 20,866 ↑ +3.3% +16.6% 15,332 ↑ +2.2% +17.9%
2021.03 2021/02/05 Q3予 130,500 ↓ -1.1% -1.1% 19,300 ↑ +13.5% +13.5% 20,200 ↑ +12.8% +12.8% 15,000 ↑ +15.4% +15.4%
2021.03 2020/11/05 Q2予 132,000 → 0.0% 0.0% 17,000 → 0.0% 0.0% 17,900 → 0.0% 0.0% 13,000 → 0.0% 0.0%
2021.03 2020/08/05 Q1予 132,000 → 0.0% 0.0% 17,000 → 0.0% 0.0% 17,900 → 0.0% 0.0% 13,000 → 0.0% 0.0%
2021.03 2020/05/11 当初予 132,000 - - - 17,000 - - - 17,900 - - - 13,000 - - -
2020.03 2020/05/11 実 123,248 ↓ -1.4% -1.4% 18,876 ↑ +11.0% +11.0% 19,649 ↑ +9.2% +9.2% 13,765 ↑ +11.9% +11.9%
2020.03 2020/02/07 Q3予 125,000 → 0.0% 0.0% 17,000 → 0.0% 0.0% 18,000 → 0.0% 0.0% 12,300 → 0.0% 0.0%
2020.03 2019/11/06 Q2予 125,000 → 0.0% 0.0% 17,000 → 0.0% 0.0% 18,000 → 0.0% 0.0% 12,300 → 0.0% 0.0%
2020.03 2019/08/02 Q1予 125,000 → 0.0% 0.0% 17,000 → 0.0% 0.0% 18,000 → 0.0% 0.0% 12,300 → 0.0% 0.0%
2020.03 2019/05/09 当初予 125,000 - - - 17,000 - - - 18,000 - - - 12,300 - - -
2019.03 2019/05/09 実 120,906 ↑ +0.3% +0.3% 18,520 ↑ +5.8% +5.8% 19,702 ↑ +9.5% +9.5% 14,593 ↑ +14.0% +14.0%
2019.03 2019/02/07 Q3予 120,500 → 0.0% 0.0% 17,500 → 0.0% 0.0% 18,000 → 0.0% 0.0% 12,800 → 0.0% 0.0%
2019.03 2018/11/06 Q2予 120,500 → 0.0% 0.0% 17,500 → 0.0% 0.0% 18,000 → 0.0% 0.0% 12,800 → 0.0% 0.0%
2019.03 2018/08/02 Q1予 120,500 → 0.0% 0.0% 17,500 → 0.0% 0.0% 18,000 → 0.0% 0.0% 12,800 → 0.0% 0.0%
2019.03 2018/05/10 当初予 120,500 - - - 17,500 - - - 18,000 - - - 12,800 - - -
2018.03 2018/05/10 実 117,879 ↓ -2.3% -2.3% 17,050 ↓ -3.1% -3.1% 17,914 ↓ -1.0% -1.0% 14,504 ↑ +14.2% +14.2%
2018.03 2018/02/07 Q3予 120,700 → 0.0% 0.0% 17,600 → 0.0% 0.0% 18,100 → 0.0% 0.0% 12,700 → 0.0% 0.0%
2018.03 2017/11/08 Q2予 120,700 → 0.0% 0.0% 17,600 → 0.0% 0.0% 18,100 → 0.0% 0.0% 12,700 → 0.0% 0.0%
2018.03 2017/08/03 Q1予 120,700 → 0.0% 0.0% 17,600 → 0.0% 0.0% 18,100 → 0.0% 0.0% 12,700 → 0.0% 0.0%
2018.03 2017/05/11 当初予 120,700 - - - 17,600 - - - 18,100 - - - 12,700 - - -
2017.03 2017/05/11 実 114,954 ↓ -0.4% -0.4% 15,983 ↑ +10.2% +10.2% 16,399 ↑ +9.3% +9.3% 12,488 ↑ +16.7% +16.7%
2017.03 2017/02/07 Q3予 115,400 → 0.0% 0.0% 14,500 → 0.0% 0.0% 15,000 → 0.0% 0.0% 10,700 → 0.0% 0.0%
2017.03 2016/08/04 Q1予 115,400 → 0.0% 0.0% 14,500 → 0.0% 0.0% 15,000 → 0.0% 0.0% 10,700 → 0.0% 0.0%
2017.03 2016/05/12 当初予 115,400 - - - 14,500 - - - 15,000 - - - 10,700 - - -
2016.03 2016/05/12 実 112,625 ↓ -0.3% -0.3% 19,826 ↑ +10.1% +10.1% 19,494 ↑ +6.5% +6.5% 12,557 ↑ +2.9% +2.9%
2016.03 2016/02/05 Q3予 113,000 → 0.0% 0.0% 18,000 → 0.0% 0.0% 18,300 → 0.0% 0.0% 12,200 → 0.0% 0.0%
2016.03 2015/11/05 Q2予 113,000 → 0.0% 0.0% 18,000 → 0.0% 0.0% 18,300 → 0.0% 0.0% 12,200 → 0.0% 0.0%
2016.03 2015/08/04 Q1予 113,000 → 0.0% 0.0% 18,000 → 0.0% 0.0% 18,300 → 0.0% 0.0% 12,200 → 0.0% 0.0%
2016.03 2015/05/12 当初予 113,000 - - - 18,000 - - - 18,300 - - - 12,200 - - -
2015.03 2015/05/12 実 110,438 ↓ -0.9% -0.9% 19,491 ↑ +7.1% +7.1% 21,583 ↑ +17.3% +17.3% 14,075 ↑ +19.3% +19.3%
2015.03 2015/02/06 Q3予 111,400 → 0.0% 0.0% 18,200 → 0.0% 0.0% 18,400 → 0.0% 0.0% 11,800 → 0.0% 0.0%
2015.03 2014/11/06 Q2予 111,400 → 0.0% 0.0% 18,200 → 0.0% 0.0% 18,400 → 0.0% 0.0% 11,800 → 0.0% 0.0%
2015.03 2014/08/01 Q1予 111,400 → 0.0% 0.0% 18,200 → 0.0% 0.0% 18,400 → 0.0% 0.0% 11,800 → 0.0% 0.0%
2015.03 2014/05/12 当初予 111,400 - - - 18,200 - - - 18,400 - - - 11,800 - - -
2014.03 2014/05/12 実 110,057 - - - 22,461 - - - 23,966 - - - 18,050 - - -
シェア ツイート
ページトップへ戻る